DrugsEstrogensProgestinsOsteoporosis is the most common skeletal diseases, predisposing the patient to an increased risk of fractures. It is an important health issue linked to increased morbidity and mortality. Prevention and treatment strategies are now well defined and are always updating. Indeed, ...
(Huayi net answer _ anti osteoporosis drug application analysis) Interpretation of the application of anti osteoporosis drugs First, the new progress in the treatment of osteoporosis 1, hip fracture (there) permanent disability C, 30% 2, estrogen application emphasizes early application, usually in ...
Patients 60 years of age or older were included if at least one prescription for any antiosteoporosis drugs had been filled in between January 1, 2006 and December 31, 2006. Persistence estimates over time (discontinuation rates were assessed at 365 days) were derived using Kaplan–Meier ...
Antidiabetic drugs (except insulin) are all pharmacological agents that have been approved for hyperglycemic treatment in type 2 diabetes mellitus (DM). If lifestyle modifications (weight loss, die...
This comprehensive meta-analysis aimed to elucidate the effects of anti-osteoporosis (OP) drugs in patients who experienced rotator cuff tears and underwent arthroscopic repair.#The PubMed, Embase, Web of Science, and Cochrane Central databases were searched to identify studies that examined the ...
This study investigates the effects of antiresorptive drugs and risk factors for medication-related osteonecrosis of the jaws in osteoporotic patients unde
More potent anti-osteoporosis drugs with fewer side effects are under intensive investigation, which relies on a better understanding of the mechanisms underlying skeletal development and regeneration. We previously discovered a C-type-lectin-domain-containing secreted factor called Clec11a/Osteolectin, ...
The present invention provides a proton pump inhibitor and an anti-osteoporosis agent and its use composite, the composite is useful for treating gastric or duodenal ulcer; a proton pump inhibitor in combination with an anti-osteoporosis drugs in bone together, synergistic effect on clinical, ...
Osteoporosis (OP) is a common disease with an increasing prevalence, in both men and women, due to longer life expectancy [1], [2]. Long-term antifracture efficacy and safety are the two major goals of any antiosteoporotic treatment [3]. Fractures (Fx) can be prevented by drugs that ha...
Actonel (Risedronate) is being used to treat or prevent osteoporosis, to strengthen the bones and to treat Paget's disease of bone. It may be used for other conditions as indicated by a doctor. Actonel slows bone loss while increasing mass of the bones, which in turn may prevent bone frac...